Yahoo

Correo

U.S. markets open in 2 hours 30 minutes

F S&P 500
5,293.50
-31.25(-0.59%)
F Dow Jones
38,730.00
-214.00(-0.55%)
F Nasdaq
18,819.00
-121.50(-0.64%)
E-mini Russell 2000 Index Futur
2,052.50
-20.70(-1.00%)
Petróleo
80.46
+0.63(+0.79%)
Oro
2,347.10
-9.40(-0.40%)

Eledon Pharmaceuticals, Inc. (ELDN)

NasdaqCM - NasdaqCM Precio en tiempo real. Divisa en USD.

Añadir a la lista de seguimiento

2.5800

-0.2400

(-8.51%)

Al cierre: 04:00PM EDT

2.5900

+0.01

(+0.39%)

Fuera de horario:

07:14PM EDT

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Divisa en USD

Compras de miembros de la gerencia en los últimos 6 meses	Acciones	Trans
Compras	0	0
Ventas	N/D	0
Acciones netas compradas (vendidas)	0	0
Acciones totales pertenecientes a miembros de la gerencia	867.47k	N/D
Acciones netas compradas (vendidas) en %	N/D	N/D

Compras institucionales netas del trimestre anterior al último	Acciones
Acciones netas compradas (vendidas)	N/D
Cambio en acciones institucionales propias en %	N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerencia	Transacción	Tipo	Valor	Fecha	Acciones
BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.40 per share.	Indirecto	4,627,049	09 may 2024	1,927,937
BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.68 per share.	Indirecto	5,303,538	05 may 2023	1,978,932
PERRIN STEVEN President	Purchase at price 2.60 per share.	Directo	2,597	23 nov 2022	1,000
GROS DAVID-ALEXANDRE C Chief Executive Officer	Purchase at price 4.48 per share.	Directo	8,960	20 dic 2021	2,000
GROS DAVID-ALEXANDRE C Chief Executive Officer	Purchase at price 6.21 per share.	Directo	24,840	17 ago 2021	4,000
LITTLE PAUL SEAN Chief Financial Officer	Purchase at price 8.87 per share.	Directo	88,700	11 jun 2021	10,000
GROS DAVID-ALEXANDRE C Chief Executive Officer	Purchase at price 8.01 per share.	Directo	24,030	09 jun 2021	3,000
BVF PARTNERS L.P. Beneficial Owner of more than 10% of a Class of Security		Indirecto		22 dic 2020	1,289,628
ORBIMED ISRAEL GP LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 21.60 per share.	Indirecto	2,229,120	02 dic 2020	103,200
LOGOS GLOBAL MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security	Purchase at price 24.03 - 26.48 per share.	Indirecto	2,341,714	30 oct 2020	92,040
LOGOS GLOBAL MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security	Sale at price 26.64 - 27.02 per share.	Indirecto	345,559	30 oct 2020	12,969
TURKEL CATHERINE C President	Sale at price 1.91 - 1.96 per share.	Directo	18,612	21 may 2019	9,537
FLESHER GREGORY J. Chief Executive Officer	Sale at price 1.91 - 1.96 per share.	Directo	28,566	21 may 2019	14,638
KUWAHARA JON S Officer	Sale at price 1.91 - 1.96 per share.	Directo	10,296	21 may 2019	5,276
ORBIMED ISRAEL GP LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.10 per share.	Indirecto	2,003,232	02 may 2019	646,204
CHIMOVITS EREZ Director	Purchase at price 3.10 per share.	Indirecto	2,003,232	02 may 2019	646,204
LIFESCI INDEX PARTNERS, LLC Beneficial Owner of more than 10% of a Class of Security	Sale at price 2.70 per share.	Indirecto	540	30 abr 2019	200
TURKEL CATHERINE C President	Stock Award(Grant) at price 0.00 per share.	Directo	0	14 mar 2019	20,000
FLESHER GREGORY J. Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	14 mar 2019	25,000
TURKEL CATHERINE C President	Purchase at price 4.56 - 5.02 per share.	Directo	161,147	12 sept 2018	33,680
TURKEL CATHERINE C President	Purchase at price 3.97 per share.	Indirecto	3,193	05 sept 2018	805
TURKEL CATHERINE C President	Stock Award(Grant) at price 0.00 per share.	Directo	0	13 mar 2018	20,000
FLESHER GREGORY J. Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	13 mar 2018	30,700
KUWAHARA JON S Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	13 mar 2018	11,250
OCAMPO CHRISTINE G Chief Financial Officer	Purchase at price 0.61 per share.	Directo	54,919	10 may 2017	90,090
TURKEL CATHERINE C Officer	Purchase at price 0.61 per share.	Directo	60,959	10 may 2017	99,999
FLESHER GREGORY J. Chief Executive Officer	Purchase at price 0.61 per share.	Directo	323,473	10 may 2017	530,631
ORBIMED ISRAEL GP LTD. Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirecto	0	09 may 2017	2,537,110
BUCKLEY STEPHEN JR Director	Purchase at price 5.74 per share.	Directo	45,920	15 mar 2016	8,000
MORRISON JODIE POPE Chief Executive Officer	Conversion of Exercise of derivative security at price 0.63 - 1.37 per share.	Directo	32,449	08 ene 2016	28,015
BUCKLEY STEPHEN JR Director	Purchase at price 11.25 per share.	Directo	33,750	11 nov 2015	3,000
MCBRIDE JOHN S Chief Operating Officer	Sale at price 14.01 per share.	Directo	189,135	21 sept 2015	13,500
MCBRIDE JOHN S Chief Operating Officer	Conversion of Exercise of derivative security at price 4.19 per share.	Directo	56,565	21 sept 2015	13,500
KALOWSKI LEE Chief Financial Officer	Sale at price 13.13 per share.	Directo	61,291	08 sept 2015	4,668
KALOWSKI LEE Chief Financial Officer	Sale at price 12.96 per share.	Directo	27,968	02 sept 2015	2,158
MORRISON JODIE POPE Chief Executive Officer	Sale at price 13.70 per share.	Directo	172,127	29 jul 2015	12,564
MORRISON JODIE POPE Chief Executive Officer	Conversion of Exercise of derivative security at price 0.63 - 1.58 per share.	Directo	28,371	29 jul 2015	22,564
MORRISON JODIE POPE Chief Executive Officer	Conversion of Exercise of derivative security at price 0.63 - 2.31 per share.	Directo	10,624	22 jul 2015	10,000
NOVARTIS BIOVENTURES, LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 14.26 per share.	Indirecto	50,844	15 jul 2015	3,566
NOVARTIS BIOVENTURES, LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 14.20 - 14.41 per share.	Indirecto	694,194	14 jul 2015	48,472
MORRISON JODIE POPE Chief Executive Officer	Sale at price 13.70 - 13.83 per share.	Directo	220,240	29 jun 2015	16,000
MORRISON JODIE POPE Chief Executive Officer	Conversion of Exercise of derivative security at price 1.58 per share.	Directo	25,280	29 jun 2015	16,000
MCBRIDE JOHN S Chief Operating Officer	Sale at price 14.00 - 14.20 per share.	Directo	126,100	24 jun 2015	9,000
MCBRIDE JOHN S Chief Operating Officer	Conversion of Exercise of derivative security at price 4.19 per share.	Directo	37,710	24 jun 2015	9,000
NOVARTIS BIOVENTURES LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 14.27 per share.	Directo	15,982	16 jun 2015	1,120
NOVARTIS BIOVENTURES LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 14.20 per share.	Directo	293,883	15 jun 2015	20,696
NOVARTIS BIOVENTURES LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 14.20 per share.	Directo	395,825	11 jun 2015	27,875
KALOWSKI LEE Chief Financial Officer	Sale at price 13.00 per share.	Directo	59,371	16 abr 2015	4,567
KALOWSKI LEE Chief Financial Officer	Sale at price 11.45 per share.	Directo	25,854	02 abr 2015	2,258
NOVARTIS BIOVENTURES LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 14.50 per share.	Indirecto	712,544	19 mar 2015	49,141
BARBERICH TIMOTHY J Director	Conversion of Exercise of derivative security at price 0.00 per share.	Directo	0	22 sept 2014	121,077
SATTER MANAGEMENT CO., L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.00 per share.	Indirecto	2,250,000	22 sept 2014	150,000
SATTER MANAGEMENT CO., L.P. Beneficial Owner of more than 10% of a Class of Security		Indirecto		22 sept 2014	1,621,688
HARRISON SETH LORING Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.00 per share.	Indirecto	5,437,500	22 sept 2014	362,500
HARRISON SETH LORING Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	22 sept 2014	7,549,570
APPLE TREE PARTNERS II L P Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Directo	0	22 sept 2014	4,218,632
APPLE TREE PARTNERS II ANNEX L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.00 per share.	Directo	3,562,500	22 sept 2014	237,500
APPLE TREE PARTNERS II ANNEX L P Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Directo	0	22 sept 2014	3,330,938
KALOWSKI LEE Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	17 sept 2014	54,604

F S&P 5005,293.50-31.25(-0.59%)

F Dow Jones38,730.00-214.00(-0.55%)

F Nasdaq18,819.00-121.50(-0.64%)

E-mini Russell 2000 Index Futur2,052.50-20.70(-1.00%)

Petróleo80.46+0.63(+0.79%)

Oro2,347.10-9.40(-0.40%)

Eledon Pharmaceuticals, Inc. (ELDN)

Transacciones de miembros de la gerencia

Información confidencial de transacciones reportada (últimos dos años)

F S&P 500
5,293.50
-31.25(-0.59%)

F Dow Jones
38,730.00
-214.00(-0.55%)

F Nasdaq
18,819.00
-121.50(-0.64%)

E-mini Russell 2000 Index Futur
2,052.50
-20.70(-1.00%)

Petróleo
80.46
+0.63(+0.79%)

Oro
2,347.10
-9.40(-0.40%)